EPs® 7630

DRUG2 trials

Sponsors

Dr. Willmar Schwabe GmbH & Co. KG, Eskisehir Osmangazi University

Conditions

Common ColdHand, Foot, and Mouth Disease

Phase 2

Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option

CompletedNCT06353477

Eskisehir Osmangazi UniversityHand, Foot, and Mouth Disease

Start: 2019-06-01End: 2023-01-01Updated: 2024-04-09

Phase 3

Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides)

CompletedNCT02174653

Dr. Willmar Schwabe GmbH & Co. KGCommon Cold

Start: 2014-03-31End: 2016-08-31Updated: 2017-01-12

Related Papers

Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study

Frontiers in Pediatrics2024-05-201 citations